ORIGINAL ARTICLE
The role of Cat -262C/T, GPX1 Pro198Leu and Sod1+35A/C gene polymorphisms in a development of primary open-angle glaucoma in a Polish population
Submission date: 2015-09-28
Final revision date: 2016-07-15
Acceptance date: 2016-08-18
Publication date: 2017-02-10
Pol J Pathol 2016;67(4):404-410
KEYWORDS
TOPICS
ABSTRACT
The development of glaucoma may be connected with a long-term exposure to oxidative stress caused by free radical (ROS). The main aim of this work was an analysis of associations of Cat-262C/T, GPX1 Pro198Leu and SOD1 35 A/C gene polymorphisms of antioxidant enzymes with a risk of open-angle glaucoma (POAG) in a Polish population.
DNA samples collected from 209 patients with POAG and 191 healthy controls were used in this study. Polymorphisms were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). We found that the +35A/C polymorphisms of SOD1 were not associated with a risk of POAG. We found that C/T genotype (1-GPX1Pro198Leu, 2-Cat C262T) is associated with increased risk of open angle glaucoma (1-OR = 2.24; 95% CI: 1.46-3.44; p = 0.0001, 2-OR = 2.16; 95% CI: 1.35-3.34; p = 0.001). We also found that T/T genotype is a risk factor for progression of POAG (1-OR = 3.86; 95% Cl: 1.36-10.96; p = 0.007, 2-OR = 6.37; 95% CI: 1.39-29.28; p = 0.007).
Finally our data suggest that gene polymorphisms of GPX1 Pro198Leu and CAT C262T may have a protective role in the development of primary open-angle glaucoma in a Polish population.
DNA samples collected from 209 patients with POAG and 191 healthy controls were used in this study. Polymorphisms were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). We found that the +35A/C polymorphisms of SOD1 were not associated with a risk of POAG. We found that C/T genotype (1-GPX1Pro198Leu, 2-Cat C262T) is associated with increased risk of open angle glaucoma (1-OR = 2.24; 95% CI: 1.46-3.44; p = 0.0001, 2-OR = 2.16; 95% CI: 1.35-3.34; p = 0.001). We also found that T/T genotype is a risk factor for progression of POAG (1-OR = 3.86; 95% Cl: 1.36-10.96; p = 0.007, 2-OR = 6.37; 95% CI: 1.39-29.28; p = 0.007).
Finally our data suggest that gene polymorphisms of GPX1 Pro198Leu and CAT C262T may have a protective role in the development of primary open-angle glaucoma in a Polish population.
REFERENCES (50)
1.
Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006; 90: 262-267.
2.
Czajkowski J. W poszukiwaniu skutecznego farmakologicznego leczenia jaskry pierwotnej otwartego kąta [Looking for effective primary open angle glaucoma pharmacological treatment]. Okulistyka 2009; 1: 19-23.
3.
Szaflik J, Zaleska-Żmijewska A, Ambroziak AM, et al. Epidemiologia jaskry – dane światowe [Worldwide data on glaucoma epidemiology]. Okulistyka 2008; 1: 13-14.
4.
Cook C, Foster P. Epidemiology of glaucoma: what’s new? Can J Ophthalmol 2012; 47: 223-226.
5.
Kowalski M, Walczak A, Majsterek I. Matrix metalloproteinases (MMPs): Modern molecular markers of open-angle glaucoma diagnosis and therapy. Postepy Hig Med Dosw (Online) 2008; 62: 582-592.
6.
Nizankowska MH, Kaczmarek R. Prevalance of glaukoma in the Wroclaw population. The Wroclaw epidemiological study. Ophthalmic Epidemiol 2005; 12: 363-371.
7.
Markiewicz L, Majsterek I, Przybylowska K, et al. Gene polymorphisms of the MMP1, MMP9, MMP12, IL-1 and TIMP1 and the risk of primary open-angle glaucoma. Acta Ophthalmol 2013; 91: 516-523.
8.
Flammer J, Orgul S, Costa VP, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 2002; 21: 359-393.
9.
Marcic TS, Belyea DA, Katz B. Neuroprotection in glaucoma: a model for neuroprotection in optic neuropathies. Curr Opin Ophthalmol 2003; 14: 353-356.
10.
Waliszek-Iwanicka A, Waliszek M, Banach MM, et al. Assessment of blood flow in posterior ciliary arteries and its correlation with intraocular and arterial blood pressures in patients with open angle glaucoma. Med Sci Monit 2010; 16: 501-509.
11.
Spector A. Oxidative stress-induced cataract: mechanism of action. FASEB J 1995; 9: 1173-1182.
12.
Rajkumar S, Praveen MR, Gajjar D, et al. Activity of superoxide dismutase isoenzymes in lens epithelial cells derived from different types of age-related cataract. J Cataract Refract Surg 2008; 34: 470-474.
14.
Mariani E, Polidori MC, Cherubini A, et al. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J Chromatogr B Analyt Technol Biomed Life Sci 2005; 827: 65-75.
15.
Cuchra M, Szymanek K, Szaflik JP, et al. Rola polimorfizmów 751lys/genuXPD oraz 939lys/glin genu XPC w rozwoju jaskry pierwotnej otwartego kąta [The role of the 751Lys/Gln XPD and 939 Lys/Gln XPC genes polymorphism in the pathogenesis of primary open-angle glaucoma]. Okulistyka 2015; 18: 13-18.
16.
Lal MA, Brismar H, Eklof AC, et al. Role of oxidative stress in advanced glycation end product-induced mesangial cell activation. Kidney Int 2002; 61: 2006-2014.
17.
Cebrian A, Pharoah PD, Ahmed S, et al. Tagging Single-Nucleotide Polymorphisms in Antioxidant Defense Enzymes and Susceptibility to Breast Cancer. Cancer Res 2006; 66: 1225-1233.
18.
Ukkola O, Erkkilae PH, Savolainen MJ, et al. Lack of association between polymorphisms of catalase, copper-zinc superoxide dismutase (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus. J Intern Med 2001; 249: 451-459.
19.
Tiwari AK, Prasad P, Kumar BKT, et al. Oxidative stress pathway genes and chronic renal insufficiency in Asian Indians with Type 2 diabetes. J Diabetes Complications 2009; 23: 102-111.
20.
Rajaraman P, Hutchinson A, Rothman N, et al. Oxidative response gene polymorphisms and risk of adult brain tumors. Neuro Oncol 2008; 10: 709-715.
21.
Bastaki M, Huen K, Manzanillo P, et al. Genotype-activity relationship for Mn-superoxide dismutase, glutathione peroxidase 1 and catalase in humans. Pharmacogenet Genomics 2006; 16: 279-286.
22.
Tan AL, Forbes JM, Cooper ME. AGE, RAGE, and ROS in diabetic nephropathy. Semin Nephrol 2007; 27: 130-143.
25.
Ishida K, Morino T, Takagi K, et al. Nucleotide sequence of a human gene for glutathione peroxidase. Nucleic Acids Res 1987; 15: 10051.
26.
Forsberg L, de Faire U, Morgenstern R. Low yield of olymorphisms from EST blast searching: analysis of genes related to oxidative stress and verification of the P197L polymorphism in GPX1. Hum Mutat 1999; 13: 294-300.
27.
Mates JM, Perez-Gomez C, Nunez de Castro CL. Antioxidant enzymes and human diseases. Clin Biochem 1990; 32: 595-603.
28.
Mueller CS, Riedel HD, Stremmel W. Direct evidence for catalase as the predominant H2O2-removing enzyme in human erythrocytes. Blood 1997; 90: 4973-4978.
29.
Forsberg L, de Faire U, Morgenstern R. Oxidative stress, human genetic variation, and disease. Arch Biochem Biophys 2001; 389: 84-93.
30.
Quan F, Korneluk RG, Tropak MB, Gravel RA. Isolation and characterization of the human catalase gene. Nucleic Acids Res 1986; 14: 5321-5335.
31.
Forsberg L, Lyrenas L, de Faire U, et al. A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. Free Radic Biol Med 2001; 30: 500-505.
32.
Malinowska K, Gacek M, Zaleska A, et al. Suplementacja melatoniną oraz związek statusu antyoksydacyjnego z patogenezą jaskry pierwotnej otwartego kąta [Supplementation of melatonin and the role of total antioxidant status]. Okulistyka 2011; 1: 97-100.
33.
Panduru NM, Cimponeriu D, Cruce M, et al. Association of +35A/C (intron3/exon3) polymorphism in SOD1-gene with diabetic nephropathy in type 1 diabetes. Rom J Morphol Embryol 2010; 51: 37-41.
34.
Suzen HS, Gucyener E, Sakalli O, et al. CAT -262C/T and GPX1 Pro198Leu polymorphisms, in a Turkish population. Mol Biol Rep 2010; 37: 87-92.
35.
Malinowska K, Szaflik JP, Majsterek I, et al. Procesy pro- i antyoksydacyjne w medycynie ze szczególnym uwzględnieniem jaskry [Pro- and antioxidant processes in medicine with particular emphasis on glaucoma]. Okulistyka 2012; 2: 60.
36.
Zhang Y, Zhang L, Sun D, et al. Genetic polymorphisms of superoxide dismutases, catalase, and glutathione peroxidase in age-related cataract. Mol Vis 2011; 17: 2325-2332.
37.
Majsterek I, Malinowska K, Stanczyk M, et al. Evaluation of oxidative stress markers in pathogenesis of primary open-angle glaucoma. Exp Mol Pathol 2011; 90: 231-237.
38.
Forsberg L, Faire U, Morgenstern R. Oxidative stress, human genetic variation, and disease. Arch Biochem Biophys 2001; 389: 84-93.
39.
Tang H, Dong X, Day RS, et al. Antioxidant genes, diabetes and dietary antioxidants in association with risk of pancreatic cancer. Carcinogenesis 2010; 31: 607-613.
40.
Flekac M, Skrha,J, Hilgertova J, et al. Gene polymorphisms of superoxide dismutases and catalase in diabetes mellitus. BMC Med Genet 2008; 9: 30.
41.
Juronen E, Tasa G, Veromann S, et al. Polymorphic glutathione S-transferases as genetic risk factors for senile cortical cataract in Estonians. Invest Ophthalmol Vis Sci 2000; 41: 2262-2267.
42.
Lin TL, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006; 443: 787-795.
43.
Truscott RJW. Age-related nuclear cataract-oxidation is the key. Exp Eye Res 2005; 80: 709-725.
44.
Faschinger, Schmut O, Wachswender C, et al. Glaucoma and oxidative stress. Determination of malondialdehyde-a product of lipid peroxidation. Ophthalmologe 2006; 103: 953-959.
45.
Tezel G. Oxidative stress in glaucomatous neurodegeneration mechanisms and consequences. Prog Retin Eye Res 2006; 25: 490-513.
46.
Tezel G, Luo C, Yang X. Accelerated aging in glaucoma immunohistochemical assessment of advanced glycation end products in the human retina and optic nerve head. Invest Ophthalmol Vis Sci 2007; 48: 1201-1211.
47.
Brennan lM, Kantorow M. Mitochondrial function and redox control in the aging eye Role of MsrA and other repair systems in cataract and macular degenerations. Exp Eye Res 2009; 88: 195-203.
48.
Hollyfield JG, Bonilha VL, Rayborn ME, et al. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med 2008; 14: 194-198.
49.
Hegde KR, Varma SD. Prevention of oxidative stress to the retina by pyruvate. A preliminary report. Ophthalmologica 2008; 222: 194-198.
50.
Izzotti A, Longobard M, Cartiglia IC, et al. Proteome alterations in primary open angle glaucoma aqueous humor. J Proteome Res 2010; 9: 4831-4838.
Share
RELATED ARTICLE
| eISSN: | 2084-9869 |
| ISSN: | 1233-9687 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
